Cargando…
Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro
BACKGROUND: Given the high occurrence of prostate cancer worldwide and one of the major sources of the discovery of new lead molecules being medicinal plants, this research undertook to investigate the possible anti-cancer activity of two natural cycloartanes; cycloartane-3,24,25-diol (extracted in...
Autores principales: | Lowe, Henry I C, Watson, Charah T, Badal, Simone, Toyang, Ngeh J, Bryant, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520828/ https://www.ncbi.nlm.nih.gov/pubmed/23151005 http://dx.doi.org/10.1186/1475-2867-12-46 |
Ejemplares similares
-
HLBT-100: a highly potent anti-cancer flavanone from Tillandsia recurvata (L.) L.
por: Lowe, Henry I. C., et al.
Publicado: (2017) -
Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential
por: Lowe, Henry, et al.
Publicado: (2021) -
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
por: Lowe, Henry, et al.
Publicado: (2021) -
(3S,12R,20S,24R)-20,24-Epoxydammarane-3,12,25-triol
por: Li, Wen-Juan, et al.
Publicado: (2011) -
Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer
por: Moreau, Michele, et al.
Publicado: (2019)